Corpus Intelligence Deal Quality 2026-04-26 14:33 UTC
Deal Quality
655 deals scored · avg quality 73.3/100 · A:313 B:338 C:4 D:0 · 41 flagged
🛡️ Public data only — no PHI permitted on this instance.
Total Deals
655
in corpus
Avg Quality
73.3
out of 100
Tier A
313
48% of corpus
Tier B
338
52% of corpus
Flagged
41
4 errors total
Quality Distribution
A:313B:338
A≥75 · B≥55 · C≥35 · D<35  |  composite = 55% completeness + 45% credibility
0102030405060708090med=72
Per-Deal Quality Scores — 50 of 655
ID Deal Tier Score Completeness Credibility Flags Missing Fields
seed_356 Steward Health Care / Cerberus Capital A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_357 Amedisys / Optum (UHG) acquisition A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_359 PhyAmerica Physician Group / Merit Hea A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_360 Surgical Care Affiliates / United Surg A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_361 Greenway Health / Vista Equity take-pr A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_362 InfuSystem / ABRY Partners LBO A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_364 Interim HealthCare / Caring Brands Int A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_365 Envision Physician Services / AmSurg / A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_366 Netsmart Technologies / GI Partners LB A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_367 IntelliSource / Cotiviti merger (Conne A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_368 National Imaging Associates / Magellan A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_370 Carecore National / AIM Specialty Heal A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_371 Gentiva Health Services / Kindred at H A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_372 American Renal Associates / Centerbrid A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_373 US Physical Therapy / Kelso & Company A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_374 Acadia Healthcare / Waud Capital LBO A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_375 ModivCare (Providence Service) / Colis A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_376 Lifespace Communities / Ryan Companies A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_377 LabCorp / Covance CRO integration A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_378 DaVita Medical Group / Optum carve-out A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_379 MedQuist / Nuance Communications healt A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_381 CONMED Corporation / Gyrus Medical acq A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_383 EXL Health / Outsourced RCM division g A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_384 Advanced ICU Care / WindRose Health In A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_385 United Behavioral Health / Optum BH ca A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_386 Adreima / Revenue Cycle Management add A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_387 Ardent Health Services / Equity Group A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_388 Sound Physicians / Summit Partners LBO A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_391 National Health Investors / Senior Car A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_393 Global Indemnity Group / specialty hea A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_394 Mednax / NP Pediatrics physician group A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_395 Vitas Healthcare / Chemed Corporation A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_396 Prospect Medical Holdings / Leonard Gr A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_398 Crossroads Hospice / LHC Group acquisi A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_399 Surgical Directions / Waud Capital LBO A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_400 Staywell Health / Carient / Population A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_401 Heritage Healthcare / ABRY Partners ad A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_402 Physicians Endoscopy / Blue Wolf Capit A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_403 National Western Life / Aon Hewitt ben A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_404 TeamHealth / IPC Healthcare merger (pr A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_406 Altus Healthcare + Rehab / Revelstoke A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_407 InCompass Health / Elevation Oncology A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_408 LHC Group / Almost Family merger A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_409 Hanger Prosthetics / Rehabilitation Ce A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_410 Acuity Brands Healthcare / Industrial A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_411 WellCare / Centene merger (second deal A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_412 Emergency Communications Network / Tri A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_413 HAH / Home at Home pediatric nursing ( A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_415 Tivity Health / Donaldson Lufkin Jenre A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
seed_416 Surgical Care Affiliates (SCA) / Frist A 83.5 70% 100% ebitda_at_entry_mm, region, state, leverage_pct
1234567891011121314
Scoring Methodology
sector20 pts
ebitda_at_entry_mm18 pts
year10 pts
source8 pts
ebitda_mm / ev_ebitda8 / 7 pts
deal_type / region / revenue6 / 6 / 5 pts
geography / state / leverage / notes4/3/3/2 pts
Start score100
MOIC ≤ 0 (error)−30
IRR < −100% (error)−20
EV ≤ 0 (error)−25
Hold ≤ 0 (error)−15
MOIC/IRR mismatch >25pp−10
EV/EBITDA outside 2–40×−8